Covered recipient · General Payments record
DENA M DAHLQUIST
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,929.93
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $191.99 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $43.11 | 2 |
| GlaxoSmithKline, LLC. | $35.84 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.09 | 2 |
| PFIZER INC. | $27.82 | 1 |
| Abbott Laboratories | $19.36 | 1 |
| Astellas Pharma US Inc | $17.81 | 1 |
| Amgen Inc. | $16.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.36 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124983797 | CMS |
| Amgen Inc. | $16.96 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117535394 | CMS |
| Astellas Pharma US Inc | $17.81 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139476712 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.66 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117959820 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.43 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117959822 | CMS |
| GlaxoSmithKline, LLC. | $13.19 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116420651 | CMS |
| GlaxoSmithKline, LLC. | $22.65 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116391274 | CMS |
| Lilly USA, LLC | $16.94 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135616169 | CMS |
| Lilly USA, LLC | $26.17 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135634312 | CMS |
| PFIZER INC. | $27.82 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131188753 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.